LENZ Therapeutics, Inc. (LENZ)

3.905 +0.18 (+4.97%) USD  |  NASDAQ  |  Sep 25, 16:00
3.905 0.00 (0.00%) After-Hours: 19:59
More

LENZ Therapeutics Research and Development Expense (Annual) : 18.67M for Dec. 31, 2025

Research and Development Expense (Annual) Chart

View Research and Development Expense (Annual) for LENZ.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Annual) Chart
Start Trial

Historical Research and Development Expense (Annual) Data

View and export this data back to 2019. Start Trial.
Date Value
December 31, 2025 18.67M
December 31, 2024 29.80M
December 31, 2023 59.50M
December 31, 2022 64.44M
Date Value
December 31, 2021 37.93M
December 31, 2020 9.123M
December 31, 2019 0.00

R&D Expense Definition

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Annual) Range, Past 5 Years

View Research and Development Expense (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Annual) Benchmarks

View Research and Development Expense (Annual) Benchmarks
Start Trial
Impact BioMedical, Inc. 0.34M
Enveric Biosciences, Inc. 2.781M
Ocular Therapeutix, Inc. 197.10M
Liquidia Corp. 38.45M
Aquestive Therapeutics, Inc. 17.19M